164 related articles for article (PubMed ID: 9863905)
1. Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer.
Gryspeerdt S; Clabout L; Van Hoe L; Berteloot P; Vergote IB
Eur J Gynaecol Oncol; 1998; 19(5):434-7. PubMed ID: 9863905
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal carcinomatosis: preoperative CT with intraperitoneal contrast material.
Nelson RC; Chezmar JL; Hoel MJ; Buck DR; Sugarbaker PH
Radiology; 1992 Jan; 182(1):133-8. PubMed ID: 1727276
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.
Drieskens O; Stroobants S; Gysen M; Vandenbosch G; Mortelmans L; Vergote I
Gynecol Obstet Invest; 2003; 55(3):130-4. PubMed ID: 12865590
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC).
Mazzei MA; Khader L; Cirigliano A; Cioffi Squitieri N; Guerrini S; Forzoni B; Marrelli D; Roviello F; Mazzei FG; Volterrani L
Abdom Imaging; 2013 Dec; 38(6):1422-30. PubMed ID: 23744439
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal contrast material improves the CT detection of peritoneal metastases.
Halvorsen RA; Panushka C; Oakley GJ; Letourneau JG; Adcock LL
AJR Am J Roentgenol; 1991 Jul; 157(1):37-40. PubMed ID: 2048534
[TBL] [Abstract][Full Text] [Related]
6. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
7. Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers.
Pannu HK; Horton KM; Fishman EK
J Comput Assist Tomogr; 2003; 27(3):333-40. PubMed ID: 12794595
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer.
Coakley FV; Choi PH; Gougoutas CA; Pothuri B; Venkatraman E; Chi D; Bergman A; Hricak H
Radiology; 2002 May; 223(2):495-9. PubMed ID: 11997559
[TBL] [Abstract][Full Text] [Related]
9. Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index.
Diaz-Gil D; Fintelmann FJ; Molaei S; Elmi A; Hedgire SS; Harisinghani MG
Abdom Radiol (NY); 2016 Nov; 41(11):2196-2202. PubMed ID: 27338731
[TBL] [Abstract][Full Text] [Related]
10. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation.
Pannu HK; Cohade C; Bristow RE; Fishman EK; Wahl RL
Abdom Imaging; 2004; 29(3):398-403. PubMed ID: 15354347
[TBL] [Abstract][Full Text] [Related]
11. [Abdominal computerized tomography in the after-care of ovarian cancers].
Gritzmann N; Karnel F; Imhof H; Wagner G; Müller-Thyl E; Dittrich C
Digitale Bilddiagn; 1986 Dec; 6(4):171-5. PubMed ID: 3816053
[TBL] [Abstract][Full Text] [Related]
12. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
[TBL] [Abstract][Full Text] [Related]
13. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
[TBL] [Abstract][Full Text] [Related]
14. Multidetector CT of peritoneal carcinomatosis from ovarian cancer.
Pannu HK; Bristow RE; Montz FJ; Fishman EK
Radiographics; 2003; 23(3):687-701. PubMed ID: 12740470
[TBL] [Abstract][Full Text] [Related]
15. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
Moro F; Bertoldo V; Avesani G; Moruzzi MC; Mascilini F; Bolomini G; Caliolo G; Esposito R; Moroni R; Zannoni GF; Fagotti A; Manfredi R; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2021 Dec; 58(6):916-925. PubMed ID: 33847427
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study.
Testa AC; Ludovisi M; Mascilini F; Di Legge A; Malaggese M; Fagotti A; Fanfani F; Salerno MG; Ercoli A; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2012 Jan; 39(1):99-105. PubMed ID: 21913276
[TBL] [Abstract][Full Text] [Related]
17. Identification and quantification of peritoneal metastases in patients with ovarian cancer with multidetector computed tomography: correlation with surgery and surgical outcome.
Metser U; Jones C; Jacks LM; Bernardini MQ; Ferguson S
Int J Gynecol Cancer; 2011 Nov; 21(8):1391-8. PubMed ID: 21997169
[TBL] [Abstract][Full Text] [Related]
18. CT Differentiation of Female Peritoneal Tuberculosis and Peritoneal Carcinomatosis From Normal-Sized Ovarian Cancer.
Shim SW; Shin SH; Kwon WJ; Jeong YK; Lee JH
J Comput Assist Tomogr; 2017 Jan; 41(1):32-38. PubMed ID: 27636249
[TBL] [Abstract][Full Text] [Related]
19. Computerized tomography of the abdomen and pelvis with peritoneal administration of soluble contrast (IPC-CT) in detection of residual disease for patients with ovarian cancer.
Frasci G; Contino A; Iaffaioli RV; Mastrantonio P; Conforti S; Persico G
Gynecol Oncol; 1994 Feb; 52(2):154-60. PubMed ID: 8314132
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
Funicelli L; Travaini LL; Landoni F; Trifirò G; Bonello L; Bellomi M
Abdom Imaging; 2010 Dec; 35(6):701-7. PubMed ID: 19784697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
